Birchview Fund
VC Fund
Burlington, United States
Birchview Fund is a VC fund in Burlington focused on Health Care and Beauty. Birchview Fund LLC
- Total investments:
- 4
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Birchview Fund invests in
Stages Birchview Fund invests in
Countries Birchview Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Matthew W. Strobeck
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 2 (50%)
- Beauty 1 (25%)
- Medical 1 (25%)
- Women's 1 (25%)
- Cosmetics 1 (25%)
Stage
- Series A 1 (25%)
- Series D 1 (25%)
- Series E 1 (25%)
- Post-IPO Equity 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Matthew W. Strobeck
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Monteris Medical
|
Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $28M / Series E / Mar 12, 2026 | |
|
Monteris Medical
|
Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $35M / Series D / Sep 13, 2022 | |
Ogee
|
Ogee is an organic skincare platform. The company adheres to organic and sustainable principles through its commitment to ethical and fair business practices through its suppliers, products, employees, partners, and community. Ogee obtained organic certification by NSF, a strict, internationally recognized standard specifically designed forpersonal care products, and uses only the highest quality natural and organic ingredients to retain the maximum level of antioxidants, polyphenols, and micronutrients in every bottle.Founded in 2014, the company is headquartered in Burlington, Vermont, United States. | $7.7M / Series A / Jun 30, 2022 | |
Aspira Women's Health
|
Aspira Women's Health develops and commercializes high-value, multi-marker, diagnostic tests that address unmet needs in gynecologic oncology and women’s health. The company is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physiciansassess risk, optimize patient management, and improve gynecologic health outcomes for women.Its OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiXSM testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. They focus on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.Aspira Women's Health was founded in 1993 and is headquartered in Austin, Texas, USA. | $10.5M / Post-IPO Equity / Dec 23, 2014 |
Co-Investors
InnovaHealth Partners
2 deals together
OSF Ventures
2 deals together
Coastal Ventures
1 deal together
FreshTracks Capital
1 deal together
Madryn Asset Management
1 deal together
Oracle Investment Management Inc.
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Birchview Fund invest in?
Birchview Fund invests primarily in Health Care, Beauty and Medical startups, most often at Series A and Series D stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Birchview Fund?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Birchview Fund?
The team at Birchview Fund includes Matthew W. Strobeck (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
